title: In situ hybridization: identification of rare mRNAs in human tissues.
abstract: In situ hybridization is used for detection of RNA expression when conservation of tissue architecture is important. Most in situ hybridization protocols are written for tissues from animals (i.e., rat) which can be harvested and preserved rapidly. In contrast, human tissue is more difficult to obtain, hence in situ hybridization experiments must frequently be performed with less than optimal tissue preservation. This procedure details hybridization of a radiolabeled single-stranded RNA probe (riboprobe) to complementary sequences of cellular RNA in human tissue sections. This method enables detection of rare mRNA species in specific cell types of human tissue, offering distinct advantages over other in situ methods due to increased sensitivity. In particular, we have found that UV cross-linking and ribonuclease treatment protocols need to be altered for human tissues to ensure successful results, making this protocol unique to those previously described. In situ hybridization experiments can be performed using either DNA or RNA probes. RNA probes are advantageous since they form stable hybrids, are single-stranded, have little or no reannealing during hybridization, and can be synthesized to high specific activity. RNA probes can be readily created utilizing SP6, T3, or T7 promoters in both sense and antisense orientations to provide non-specific (control) and specific probes. Disadvantages of RNA riboprobes include a tendency for RNA to stick non-selectively more than DNA, and degradation by RNase (hence strict adherence to RNase-free precautions is mandatory during most of the protocol). The following protocol includes: (1) preparation of human tissues (tissue fixation and sectioning are highlighted as critical for probe penetration, preservation of tissue architecture, retention of tissue RNA, and overall success); (2) generation of radiolabeled riboprobes (total incorporation of radionucleotide is important to increase sensitivity; 35S was chosen as a compromise between excellent sensitivity, cellular resolution, and required exposure times (compared with 32P or 3H); non-isotopic methods have not been tested in a side-by-side comparison with 35S in human tissues by us, but theoretically might offer faster exposure times while maintaining high resolution); (3) hybridization conditions (stringency, temperature, washes, tissue dehydration); and (4) sample visualization (application of photographic emulsion, developing, fixing, staining, and counterstaining of individual slides).
authors.affiliation: Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: K H
authors.initials: KH
authors.lastname: Wilson
authors.forename: U B
authors.initials: UB
authors.lastname: Schambra
authors.forename: M S
authors.initials: MS
authors.lastname: Smith
authors.forename: S O
authors.initials: SO
authors.lastname: Page
authors.forename: C D
authors.initials: CD
authors.lastname: Richardson
authors.forename: R T
authors.initials: RT
authors.lastname: Fremeau
authors.forename: D A
authors.initials: DA
authors.lastname: Schwinn
mesh_terms: D006801:Humans; D017403:In Situ Hybridization / Q000379:methods*; D012333:RNA, Messenger / Q000032:analysis*; D011942:Receptors, Adrenergic, alpha / Q000235:genetics; D013116:Spinal Cord / Q000737:chemistry
chemical_list: D012333:RNA, Messenger; D011942:Receptors, Adrenergic, alpha